Medserve

Book an appointment
Book an appointment
Book an appointment
Speak to someone

Advanced Healthcare For Every Nigerian

MedServe is transforming the Nigerian healthcare landscape with mordern infrastructure and cutting-edge medical technology, using a patient-centered approach.

About Medserve

NSIA Advanced Medical Services Limited (MedServe) is the dedicated healthcare subsidiary of the Nigeria Sovereign Investment Authority (NSIA), established to provide world class, accessible, and affordable healthcare services across Nigeria.

With a mission to transform the medical landscape, MedServe is driving innovation through cutting edge advanced medical technology, and a strong patient-centred approach.

Currently, MedServe manages NSIA’s three state of the art medical facilities, designed to enhance diagnostic and cancer care services: the MedServe LUTH Cancer Centre (MLCC), an oncology centre providing advanced cancer treatment; the MedServe Kano Diagnostic Centre (MKDC) and the MedServe Umuahia Diagnostic Centre (MUDC), offering comprehensive imaging and laboratory diagnostic services. These pioneering centres, staffed by highly skilled healthcare professionals, have set new benchmarks in medical excellence, ensuring that patients can receive top-tier treatment without the need to travel abroad.

MedServe evolved from the NSIA Healthcare Development and Investment Company (NHDIC), established in 2018 to address critical healthcare gaps and elevate service standards to international levels.

Under NHDIC, NSIA successfully developed these initial medical centres, laying a strong foundation for a more ambitious, nationwide healthcare expansion.

Building on this success, NSIA has launched its Healthcare Expansion Programme, a bold initiative aimed at improving healthcare accessibility and patient outcomes across the country. This programme will establish 23 modern medical diagnostic centres to enhance early disease detection and preventive healthcare.

Within these 23 diagnostic centres, three will include comprehensive oncology centres to expand access to advanced cancer treatment and reduce mortality rates, and seven catheterization laboratories to provide life-saving cardiac care and interventional cardiology services.

This expansion underscores NSIA’s commitment to strengthening Nigeria’s healthcare system, ensuring that high-quality medical services reach every region. Through strategic investments in advanced medical technology, capacity building, and infrastructure development coupled with an unwavering focus on patient care, MedServe is positioning Nigeria as a leading hub for medical excellence in Africa.

Our Mission

To set the standard of excellence in healthcare, to advance medicine through cutting-edge research, and to uplift every community we serve.

Our Vision

To lead from the front as we continue to grow and raise the bar in healthcare and medicine by providing affordable, accessible and accurate healthcare services across the nation.

Our Values

At MedServe, our core values guide everything we do as we work to transform healthcare in Nigeria.

Excellence

We strive to be the best by constantly innovating and improving.

Integrity

We hold ourselves to the highest ethical standards in order to earn and keep your trust.

Teamwork

Healthcare works better together and that means we value input from everyone on the team; from staff, to patients, to family.

Empathy

We believe the best kind of care is holistic, so we nurture and maintain an understanding and compassionate environment to help you heal.

Our Leadership Team

Edit Content

Mr. Aminu Umar-Sadiq

Chairman

Mr. Umar-Sadiq is the Chairman Board of Directors of the NSIA Advanced Medical Services Limited (MedServe). He currently serves as the Managing Director and Chief Executive Officer of the Nigeria Sovereign Investment Authority (NSIA), with significant experience in the global financial services sector – spanning public finance management, mergers & acquisitions, private equity, and asset management.

Prior to this appointment as MD & CEO in October 2022, Aminu was an Executive Director and Head of Direct Investments (from February 2019) at NSIA, leading NSIA’s multi-product, cross-sector domestic infrastructure fund. He was also responsible for corporate governance management and performance reporting for NSIA’s over 10 subsidiary entities.

Mr. Umar Sadiq has strong antecedents from Morgan Stanley, where he initiated his professional journey in the mergers & acquisitions division, subsequently proceeding to Denham Capital Management, a natural resource-focused private equity fund, and then to the mergers and acquisitions division at Société Générale.

He serves on the following Boards in a non-executive capacity including the Infrastructure Credit Guarantee Company Limited (InfraCredit), Development Bank of Nigeria (DBN), Nigeria Mortgage Refinance Company (NMRC), NSIA Advanced Medical Services Limited (MedServe), Green Guarantee Company and Carbon Vista.

He serves as a member of the EU High-Level Expert Group on Sustainable Finance for Emerging Economies, contributing his vast experience to shape sustainable financial strategies in developing markets. Additionally, his role on the Sustainable Investment Advisory Council for the United Nations Conference on Trade and Development highlights his dedication to aligning global trade and investment practices with sustainable development goals.

Mr. Umar-Sadiq attained his bachelor’s and master’s degrees in engineering sciences from the University of Oxford (St Johns College). He has also attended a plethora of advanced management programs for senior management executives.

Close

Chairman

Edit Content

Mrs. Ijeoma Taylaur

Non-Executive Director

Mrs. Taylaur is a Non-Executive Director NSIA Advanced Medical Services Limited (MedServe). Currently, Mrs. Taylaur serves as the Executive Director and Chief Operating Officer at the Nigeria Sovereign Investment Authority (NSIA). She is an experienced Business/Finance Executive (FCA) with over 27 years of extensive professional experience across Financial & Business Advisory, Corporate & Management Finance, Private Equity portfolio management, and Audit Assurance.

Prior to joining NSIA, Ijeoma was an Executive Director at Alpha African Advisory (AAA) –formerly Travant Capital Partners, an Africa-focused financial advisory firm. Here, she led the gateway services division, providing a range of market entry assistance services. She also played a pivotal role in the origination and execution of financial and business advisory mandates which included financial restructuring, due diligence, and valuation transactions. Additionally, she managed all aspects of the Finance & Accounting function. During her tenure at Travant Capital Partners, she was responsible for investor relations, fund administration, and fund accounting services in managing a partially deployed US$107M private equity fund (Travant Private Equity Fund 1).

Before her roles at AAA / Travant Capital Partners, Ijeoma spent over 10 years with PricewaterhouseCoopers (PwC) in their Lagos and London offices. At PwC, she managed teams providing external audit assurance and business advisory services to companies within a broad range of sectors, including banks, financial services institutions, and multinational upstream companies.

Ijeoma holds a bachelor’s degree in Accountancy and is a Fellow of the Institute of Chartered Accountants of Nigeria (FCA). She is also a member of the Chartered Institute of Taxation of Nigeria and the Chartered Institute of Directors (IoD).

Close

Non-Executive Director

Edit Content

Mr. Kolawole Owodunni

Non-Executive Director

Mr Owodunni is a Non-Executive Director of the NSIA Advanced Medical Services Limited (MedServe). Currently, he serves as an Executive Director and Chief Investment Officer (CIO) at the Nigeria Sovereign Investment Authority (NSIA). 

Kolawole is a consummate professional with over two decades of cognate experience, principally in the financial services sector spanning Investment Management, Risk Management and Treasury.

He is responsible for deploying capital across various investment mandates for NSIA. Before NSIA, Kolawole was Head of Risk Management at Dunn Loren Merrifield. Before that, he worked as a Risk Manager at Credit Suisse, London.

He was also a member of the pioneer team that started the Hedge Fund Development and Management Group at Merrill Lynch (now Bank of America Merrill Lynch) in London.

A Goldman Sachs alumnus, he holds a Master’s degree in Chemical Engineering from Imperial College, London and an MBA from INSEAD, France. He is also a CFA Charter-holder.

Close

Non-Executive Director

Edit Content

Dr. Tolulope Adewole

Managing Director & Chief Executive Officer

Dr. Adewole is the Managing Director and Chief Executive Officer of NSIA Advanced Medical Services Limited (MedServe). He is a highly regarded healthcare expert with over two decades of diverse experience, spanning clinical practice, healthcare management, and executive leadership. His academic journey began at the University of Ibadan, followed by a medical internship at Lagos University Teaching Hospital and a Residency Program in Chemical Pathology at the University College Hospital, Ibadan, where he earned a Fellowship from the National Postgraduate Medical College of Nigeria. In addition to his medical training, he completed a Healthcare Management certificate program at the University of Washington. He is also a distinguished member of several professional organizations, including the American Diagnostic and Laboratory Medicine (ADLM) and the American Association of Clinical Oncologists (ASCO). 

In 2019, Dr. Adewole was appointed CEO of NSIA Healthcare Development & Investment Company (NHDIC), where he oversaw healthcare projects valued at $21 million, primarily focused on cancer care and diagnostics across Nigeria. Following his appointment as the CEO MedServe, he is leading the Healthcare Expansion Programme, an ambitious initiative involving the development and operationalisation of 23 modern medical diagnostic centres, 3 oncology centres, and 7 catheterization laboratories, with a projected cost of approximately $280 million. 

He also contributes to the healthcare industry in Nigeria through his role on the Finance Committee of the Healthcare Federation of Nigeria and as a board member for the Covenant University World Bank Project and the Bloomberg New Economy International Coalition Against Cancer. 

In 2025, Dr. Adewole was nominated as a Member of the National Technical Working Group on Nuclear Medicine in Nigeria, an advisory body established by the Federal Ministry of Health and Social Welfare to guide the implementation and expansion of nuclear medicine services across the country. Recognised for his expertise in healthcare financing, strategy, and quality improvement, his contributions have been acknowledged by prestigious organizations such as the Institute of Directors, the Society for Quality in Healthcare, and Cure4Cancer. With a strong track record of leadership in healthcare transformation, Dr. Adewole continues to drive impactful projects that enhance access to high-quality medical services in Nigeria and beyond.

Close

Managing Director & Chief Executive Officer

Locations

MedServe is transforming the Nigerian healthcare landscape with advanced medical technology, cutting-edge infrastructure, and a patient-centered approach. MedServe has three state of the art medical facilities, designed to enhance diagnostic and cancer care services across Nigeria.

MedServe Umuahia Diagnostic Centre (MUDC)

MUDC Located in Umuahia, Abia State, provides advanced diagnostic care to patients across the South-East region. Our modern facility is equipped with cutting-edge technology and ...
Read More

MedServe Kano Diagnostic Centre (MKDC)

MKDC, located in Kano, the commercial hub of Northern Nigeria, delivers advanced diagnostic care to patients across the region. Our state-of-the-art facility is supported by ...
Read More

MedServe LUTH Cancer Centre (MLCC)

MLCC is a high-volume outpatient oncology centre that delivers world-class cancer care to patients. Established in 2019, the centre is located within the Lagos University ...
Read More

Our Partners